Navigation Links
UT Southwestern researchers create molecule that nudges nerve stem cells to mature
Date:6/15/2008

DALLAS June 15, 2008 Inspired by a chance discovery during another experiment, researchers at UT Southwestern Medical Center have created a small molecule that stimulates nerve stem cells to begin maturing into nerve cells in culture.

This finding might someday allow a person's own nerve stem cells to be grown outside the body, stimulated into maturity, and then re-implanted as working nerve cells to treat various diseases, the researchers said.

"This provides a critical starting point for neuro-regenerative medicine and brain cancer chemotherapy," said Dr. Jenny Hsieh, assistant professor of molecular biology and senior author of the paper, which appears online today and in the June 17 issue of Nature Chemical Biology.

The creation of the molecule allowed the researchers to uncover some of the biochemical steps that happen as nerve cells mature. It also showed that large-scale screening of compounds can provide starting points for developing drugs to treat disorders such as Huntington's disease, traumatic brain injury or cancer.

The scientists began this project as a result of a separate study in which they were screening 147,000 compounds to see which could stimulate stem cells cultivated from rodent embryos to become heart cells. Unexpectedly, five molecules stimulated the cells to transform into forms resembling nerve cells. The researchers then created a variation of these molecules, a new compound called Isx-9 (for isoxazole-9). Isx-9 was easier to use than its initially discovered relatives because it worked at a much lower concentration and also dissolved more easily in water.

"It was completely serendipitous that we uncovered this neurogenic [nerve-creating] small molecule," Dr. Hsieh said. "I think it's one of the most powerful neurogenic small molecules on the planet. In theory, this molecule could provoke full maturation, to the point that the new nerve cells could fire, generating the electric
'/>"/>

Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Geology and biology meet in the history of US southwestern desert surface waters
2. Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research
3. Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find
4. UT Southwesterns Mangelsdorf elected to National Academy of Sciences
5. NIH awards $6.5 million grant to UT Southwestern to develop new antibiotic
6. Stem-cell transplantation improves muscles in MD animal model, UT Southwestern researchers report
7. UT Southwestern scientist honored among best in Texas research
8. UT Southwestern secures $5 million NIH grant for lupus research
9. BMI criteria for obesity surgery should be lowered, UT Southwestern researcher suggests
10. UT Southwestern researchers identify hundreds of genes controlling female fertility
11. Researchers reveal insights into hidden world of protein folding

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ining grant in the amount of $2,756,719 by the Nat...duation Education and Research Training (IGERT) pr... to Kent State. The grant, which is funded under t... runs through 2014. , The grant funds an IGERT p...e sensing (EARS). The purpose of the program is to...
(Date:11/4/2009)...g Beach and Riverside are responsible for a signif...and the true impact of air pollution and ship emis...d, according to researchers at the University of S...pears in an online edition of the American Journa...f all childhood asthma cases in Long Beach and six...
(Date:11/4/2009)... DNA codes, or genomes, of the famed fugu (or puff...10K Project, an international effort to build an i...ecies of animals for conducting comparative studie..., Participating in The Genome 10K project, descri... of the Journal of Heredity , are 70 leading scie...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USC study finds big air pollution impacts on local communities 2Singapore scientists join international study of 10,000 vertebrates' genomes 2Radiology Benefit Management Could Save Medicare up to 2418 Billion Over 10 Years 51941 1Radiology Benefit Management Could Save Medicare up to 2418 Billion Over 10 Years 51941 2Radiology Benefit Management Could Save Medicare up to 2418 Billion Over 10 Years 51941 3Scientists Reverse Muscular Dystrophy in Mice 51938 1Scientists Reverse Muscular Dystrophy in Mice 51938 2Scientists Reverse Muscular Dystrophy in Mice 51938 3Arcadian Chairman and Chief Executive Officer Robert Fahlman to Present at Focus on Healthcare Conference in New York City 51935 1
...y the National Institute on Drug Abuse (NIDA), par...he first time identified genes that might increase...reakthrough research was conducted by Dr. George U...m led by Dr. Jed Rose at the Center for Nicotine a...edical Center. , The study, published in the journ...
... of Allergy and Infectious Diseases (NIAID), part ...announced it is awarding $23 million per year for ... for Influenza Research and Surveillance. Collecti...rveillance program internationally and in the Unit...key areas, including understanding how the virus c...
...n that reduced calorie intake can increase health ...ity of California) and his collaborators* have dis... can still induce many of the health and longevity...tly, this also includes anti-cancer effects. , Th...creening technique to find drugs which mimic this ...
Other Biology News:NIDA study identifies genes that might help some people abstain from smoking 2NIAID expands capability for influenza research and surveillance 2NIAID expands capability for influenza research and surveillance 3NIAID expands capability for influenza research and surveillance 4It's never too late to get it back! Aging interrupted 2
(Date:11/5/2009)...DOVA, Calif., Nov. 5 The...ier of innovative products for processing and stor...he first quarter of fiscal 2010. ,, For the qua...d revenues of $5.2 million, a 15 percent increase ... a year ago. The Company said the key contributors...
(Date:11/5/2009)...., Nov. 5 Transgenomic, ...nancial results for the quarter ended September 30...ted in the tables that follow. ,, Third Quarte...366,000 or $0.01 per share for the third quarter o....01 per share for the third quarter of 2008. ,...
(Date:11/5/2009)... Calif., Nov. 5 Cepheid ...es will be speaking at the following investor conf...webcast. , , Credit Suisse Healthc...day, 12 November, 2009 at 10 a.m. Mountain Time, ...London, England, Tuesday, 1 Decemb...
(Date:11/5/2009)... CA, November 5, 2009 Se... using proprietary taste receptor-based technologi...od, beverage, and ingredient supply industries, to...cial results for the third quarter ended September...rd quarter of 2009, compared to $4.0 million for t...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...IN LAKES, N.J., March 13 Medco Health,Solutions, ...eed to sell $300,million aggregate principal amoun... and $1.2 billion aggregate principal amount of 7-...underwritten public offering. Citi,J.P. Morgan Sec...arclays,Capital Inc. are acting as representatives...
... Generation Treatment from Abbott Shows No Thrombo...ary Clinical Study of Thirty Patients, ABBOTT PAR...cet from ABSORB, the world,s first clinical trial ...e treatment of coronary artery,disease, demonstrat...t,lesion revascularizations (retreatment of a dise...
...EY, Calif., March 13 Nile Therapeutics,Inc. (OTC ...quarter and,full year financial results for 2007. ...e conference call from the investor relations sect... . The webcast will remain available on,the compan...ll., For the fourth quarter of 2007, Nile reporte...
Other Biology Technology:Medco Issues $1.5 Billion of Senior Notes 2Medco Issues $1.5 Billion of Senior Notes 3The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 2The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 3The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 4Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 2Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3
Luminex 100 IS System from Luminex Corporation
GIBCO Water distilled from Invitrogen
Rabbit Anti-Bovine Respiratory Syncytial Virus Bovine Respiratory Syncytial Virus Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-MacMarcks Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: